Friday, August 7, 2009

Vytorin and Zetia Settlement

The New York Times reported yesterday that Merck and Schering-Plough have agreed to pay $41.5 million to settle class claims that they withheld the results of an unfavorable clinical trial.  The clinical trial apparently linked Vytorin and Zetia to harmful side effects that included cancer.  Of course, this news comes as both companies are in merger talks, which would make Merck the second largest pharmaceutical company in the world.  The New York Times article is available here.


Class Actions, Pharmaceuticals - Misc., Settlement | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Vytorin and Zetia Settlement:


Where does one obtain a claim form. It says to go to this web site but, I could not locate a form.

Posted by: Bill McNamara | Oct 26, 2009 8:21:05 AM

There seem to be several law firms involved in this. How do I select and sign up with the appropriate firm?

Posted by: Joyce Williamson | Nov 5, 2009 3:17:06 PM

I saw the ad regarding a suit over these products last night on television. I cannot find the form to fill out either. My doctor put me on Zetia for several months and the only thing that happened was my cholesterol and tri-gycerides rose. I spent a large amount of money for that privelege and sure would like to get some back.

Posted by: lorelei carr | Nov 14, 2009 10:32:45 AM

I Have been on vytorin since zorco sent generic.

How do I find out about the class action suit

filed against vytorin/zetia. Thanks

Posted by: John Blaine | Nov 17, 2009 8:42:18 AM

Post a comment